Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4fl3 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4fl3 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 1.000 | |
| 4fl2 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.607 | |
| 2ozo | ANP | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.519 | |
| 4k2r | ANP | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.518 | |
| 1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.508 | |
| 5cnn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.504 | |
| 4lfi | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.485 | |
| 5cno | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.484 | |
| 3p23 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.482 | |
| 3vn9 | ANK | Dual specificity mitogen-activated protein kinase kinase 6 | 2.7.12.2 | 0.482 | |
| 2z7q | ACP | Ribosomal protein S6 kinase alpha-1 | 2.7.11.1 | 0.471 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.470 | |
| 4pl4 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.465 | |
| 3orp | AGS | Serine/threonine protein kinase | / | 0.464 | |
| 3pls | ANP | Macrophage-stimulating protein receptor | 2.7.10.1 | 0.463 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.463 | |
| 3c4z | ADP | Rhodopsin kinase | / | 0.460 | |
| 3nie | ANP | Mitogen-activated protein kinase | / | 0.458 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.458 | |
| 1jnk | ANP | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.454 | |
| 4dee | ADP | Aurora kinase A | 2.7.11.1 | 0.454 | |
| 4fg9 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.451 | |
| 1b38 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.449 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.449 | |
| 1day | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.448 | |
| 3oro | AGS | Serine/threonine protein kinase | / | 0.447 | |
| 1daw | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
| 4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.445 | |
| 4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
| 1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.444 | |
| 1ig1 | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.444 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.444 | |
| 1mru | AGS | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.443 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.442 | |
| 4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.442 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
| 1b39 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 1hck | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.440 |